A new bone marrow test can help doctors predict risk of leukemia relapse The test might double survival rates by predicting a relapse up to three months earlier than standard care The test looks for ...
Survival disparities in patients with acute lymphoblastic leukemia: A focus on young adult and adolescent patients. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Orca-T significantly improved survival free of moderate-to-severe cGvHD compared to alloHSCT, with rates of 78% versus 38%. Orca-T demonstrated a lower incidence of severe acute GvHD and non-relapse ...
Targeted maintenance therapy with gilteritinib (Xospata; Astellas) following allogeneic hematopoietic stem cell ...
Acute myeloid leukemia (AML) has a poor prognosis, especially in elderly and relapsed/refractory patients, with 5‑year ...
Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia treated at specialized cancer centers have significantly higher survival rates than their peers who are not ...
MONDAY, May 5, 2025 (HealthDay News) — Testing positive for leukemia actually saved the life of 51-year-old Jan Leahy, a business process owner from Wimbledon, England. Leahy benefitted from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results